People with health issues or inactivated vaccine should get booster: WHO

The recommendation comes after the Strategic Advisory Group of Experts on immunisation held a meeting on Tuesday to evaluate the need for Covid boosters

vaccination
Photo: Bloomberg
Reuters
2 min read Last Updated : Dec 09 2021 | 4:27 PM IST
The World Health Organization's (WHO) vaccine advisory panel recommends that people who are immunocompromised or received an inactivated vaccine should receive a booster dose of a COVID-19 shot, it said on Thursday.
 
Many countries have been rolling out booster shots, targeting the elderly and people with underlying health issues, but worries about the new Omicron variant have prompted some to expand their use to larger portions of their populations.

With vaccination rates worryingly low in much of the developing world, the WHO has said in recent months that administering primary doses - rather than boosters - should be a priority.
 
The recommendation comes after the Strategic Advisory Group of Experts (SAGE) on immunisation held a meeting on Tuesday to evaluate the need for COVID-19 boosters.
 
Speaking in a briefing, SAGE chair Alejandro Cravioto said emerging data showed that vaccines' efficacy against COVID-19 wanes, with a significant decline seen in older people in particular.
 
COVID-19 vaccines protect "very well" through six months after the last dose with some "minor, modest reduction" in protection, Kate O'Brien, director of the WHO's immunisation department, said.
 
Inactivated vaccines which take the SARS-CoV-2 virus and inactivate or kill it using chemicals, heat or radiation, are made by Chinese manufacturers Sinovac Biotech, state-owned Sinopharm and India's Bharat Biotech.
 
A single dose of the Johnson & Johnson vaccine is still effective, but data from the company's clinical trials using two doses clearly show the benefit of having further vaccination, Cravioto said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

Next Story